Last week, Tanya Hall spoke on a panel at the annual event of BioPharmaDispatch. A platform for the biopharmaceutical industry, its leaders, patients and key decision-makers to discuss issues impacting access to the latest healthcare technologies.
The panel discussion was with Professor John Zalcberg OAM and BIOPharmaDispatch founder Paul Cross on the complexities of the Health Technology Assessment review.
